1. Issue Highlights Clinical Gastroenterology and Hepatology
Stephen B. Hanauer 
Clinical Gastroenterology and Hepatology 
Volume 13, Issue 3, Pages (March 2015)
DOI: /j.cgh
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 3
Predictive role of risk panel. Relapse and colectomy rate based on a risk panel including 5 independent risk factors, namely absence of short-term complete clinical response, absence of short-term mucosal healing, pANCA positivity, baseline albumin level less than 35 g/L, and baseline CRP level greater than 5 mg/L: (A) time to relapse, (B) time to colectomy, (C) clinical relapse rate within 12 months, and (D) colectomy rate within 60 months.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2015 AGA Institute Terms and Conditions

3. Figure 4
Proposed algorithm for discontinuation of immunomodulator (IMM) in patients with durable response under combination treatment. ADA, adalimumab; IFX, infliximab; TL, trough level; TNF, tumor necrosis factor.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2015 AGA Institute Terms and Conditions